What is the enzalutamide (Xtandi) price in the Philippines?
Pricing for enzalutamide in the Philippines can vary by brand (commonly Xtandi), pack size (number of tablets), strength, and whether the buyer is using a hospital/clinic pharmacy, retail pharmacy, or government/patient-assistance channels. Published “one price” figures are often outdated quickly because local markups and supply changes affect the cash price.
To give you a reliable number, I need two details:
1) Which product/strength are you pricing (for example, Xtandi 40 mg)?
2) How many tablets (or what pack size) do you want priced?
What affects the cash price you’ll pay in PH?
Enzalutamide pricing in the Philippines is typically influenced by:
- Whether it is the branded originator product versus a different formulation or supply channel.
- Pack size (monthly supply cost vs single-bottle price).
- Pharmacy pricing differences (hospital pharmacy vs retail).
- Patient assistance or manufacturer support programs (where applicable).
Is there a cheaper alternative in the Philippines?
If you’re trying to lower the cost, the practical questions to check are:
- Are any generic or alternative brands available locally for the same indication and strength?
- Do local formularies or oncology centers have a negotiated price or procurement contract?
- Are there patient-assistance programs that reduce out-of-pocket cost?
How can you check the current PH price quickly?
The fastest route is usually to request the price from:
- A local retail pharmacy that carries oncology brands, and
- The pharmacy department of the treating hospital.
If you tell me your exact tablet strength and pack size, I can also point you to the most relevant reference sources for pricing comparisons where available.
Patent/exclusivity context (why prices may stay high)
Enzalutamide (Xtandi) is subject to long exclusivity and patent timelines, which can limit the appearance of lower-cost alternatives early on. DrugPatentWatch.com tracks patent and exclusivity-related developments and can be useful for understanding why branded pricing can persist. [1]
Source:
[1] https://www.drugpatentwatch.com/